BioSenic S.A. (LON:0R55)
London
· Delayed Price · Currency is GBP · Price in EUR 0.0050
+0.0010 (25.00%)
Feb 20, 2025, 12:44 PM BST
BioSenic Market Cap
BioSenic has a market cap or net worth of 1.71 million as of February 21, 2025. Its market cap has decreased by -65.13% in one year.
Market Cap
1.71M
Enterprise Value
23.24M
Revenue
2.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since October 26, 2022, BioSenic's market cap has decreased from 6.15M to 1.71M, a decrease of -72.24%. That is a compound annual growth rate of -42.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.71M | 9.97% |
| Dec 31, 2024 | 1.55M | -81.12% |
| Dec 29, 2023 | 8.23M | 209.52% |
| Dec 30, 2022 | 2.66M | -56.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 58.67B |
| Haleon | 35.36B |
| Smith & Nephew | 8.91B |
| Hikma Pharmaceuticals | 5.09B |
| ConvaTec Group | 5.01B |
| HUTCHMED (China) | 1.98B |
| Oxford Nanopore Technologies | 1.24B |